Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

Obesity Sciences & Innovation 2026

Boston, United States | 23 September 2026 - 24 September 2026
Overview

Connect with Quotient Sciences’ experts who will be attending Obesity Sciences & Innovation 2026 conference, taking place in Boston, MA, September 23-24, 2026.

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Hynes Convention Center
900 Boylston St., MA 02115
Boston, United States

Meet our experts:

We look forward to meeting you at ISSX this October.

Jennifer Goldberg

Senior Director, Business Development

Jennifer Goldberg brings over two decades of experience in pharmaceutical business development, with a focus on drug product manuf...

About Jennifer
Iain Shaw

Senior Director, 14C Enabled Drug Development

Iain Shaw has over 30 years of experience in the pharmaceutical industry, including over 15 years focused on 14C-enabled drug deve...

About Iain
Adam Ball

Associate Director, Business Development

Adam Ball has worked at Quotient Sciences for over 7 years, starting in manufacturing in 2018 before moving into the commercial te...

About Adam

More insight from our experts:

Read More
Drug Product, Pediatrics, Nazim Kanji A Comparison of FDA and EMA Expectations for Oral Drug Administration Through Enteral Feeding Tubes
Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Pediatrics, Formulation Development, Drug Product A Comprehensive Approach to Pediatric Drug Products: Q&A with Nazim Kanji
Read More
Read More